<Disease><Name>WOODHOUSE-SAKATI SYNDROME</Name><Synonym>HYPOGONADISM, ALOPECIA, DIABETES MELLITUS, MENTAL RETARDATION, DEAFNESS, AND EXTRAPYRAMIDAL SYNDROME</Synonym><OMIM><Number>241080</Number><URL>http://omim.org/entry/241080</URL></OMIM><Orphanet><Number>3464</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=3464</URL></Orphanet><Protein><Number>DDB1- and CUL4-associated factor 17</Number><URL>http://www.uniprot.org/uniprot/Q5H9S7</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>2q31.1</Gene><ICD>Q87.8</ICD><Summary>rare;autosomal recessive;mutation in the C2ORF37 gene</Summary><Symptoms><symtomp><id>2233</id><symptom>alopecia</symptom><category>SKIN | SKIN</category></symtomp><symtomp><id>2113</id><symptom>amenorrhea</symptom><category>ENDOCRINE SYSTEM | GENITOURINARY TRACT</category></symtomp><symtomp><id>3813</id><symptom>craniofacial anomalies</symptom><category>HEAD</category></symtomp><symtomp><id>3062</id><symptom>diabetes mellitus</symptom><category>GASTROINTESTINAL SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1883</id><symptom>ECG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2019</id><symptom>hair, abnormal  (thin, brittle, fine)</symptom><category>SKIN</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3689</id><symptom>hypogonadism</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2053</id><symptom>hypothyroidism</symptom><category>ENDOCRINE SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2228</id><symptom>micropenis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3824</id><symptom>ovarian failure</symptom><category>ENDOCRINE SYSTEM | GENITOURINARY TRACT</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>942</id><name>Insulin-like growth factor I(IGF-I)</name><specimen>serum</specimen><value>decreased</value><min>0.10</min><max>95.00</max><unit>percentile</unit><age>&lt;8 years</age><method /><comment /></metabolite><metabolite><id>945</id><name>Insulin-like growth factor I(IGF-I)</name><specimen>serum</specimen><value>decreased</value><min>0.10</min><max>95.00</max><unit>percentile</unit><age>&gt;8 years</age><method /><comment /></metabolite><metabolite><id>1173</id><name>Insulin-like growth factor I(IGF-I)</name><specimen>serum</specimen><value>decreased</value><min>87.00</min><max>895.00</max><unit>ng/ml</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>486</id><name>Thyroid-stimulating hormone (TSH)</name><specimen>serum</specimen><value>increased</value><min>2.00</min><max>4.00</max><unit>mU/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1053</id><name>Thyroid-stimulating hormone (TSH)</name><specimen>serum</specimen><value>increased</value><min>0.30</min><max>3.10</max><unit>mU/l</unit><age>5-10 years</age><method /><comment /></metabolite><metabolite><id>824</id><name>Thyroxine (T4)</name><specimen>serum</specimen><value>decreased</value><min>7.00</min><max>15.00</max><unit>&#181;g/dl</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1044</id><name>Thyroxine (T4)</name><specimen>serum</specimen><value>decreased</value><min>8.90</min><max>23.60</max><unit>&#181;g/dl</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1045</id><name>Thyroxine (T4)</name><specimen>serum</specimen><value>decreased</value><min>7.60</min><max>14.00</max><unit>&#181;g/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1046</id><name>Thyroxine (T4)</name><specimen>serum</specimen><value>decreased</value><min>6.20</min><max>12.90</max><unit>&#181;g/dl</unit><age>&gt; 10years</age><method /><comment /></metabolite><metabolite><id>1047</id><name>Thyroxine (T4)</name><specimen>serum</specimen><value>decreased</value><min>6.90</min><max>13.70</max><unit>&#181;g/dl</unit><age>5-10 years</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>5127</id><title>Woodhouse-Sakati Syndrome</title><author>Bohlega SA,</author><journal>GeneReviews&#174; [Internet]</journal><year>2016</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Alkuraya FS</co_aut></literature><literature><id>5128</id><title>Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature</title><author>Agopiantz M,</author><journal>J Endocrinol Invest</journal><year>2014</year><book /><volume>37</volume><number>1</number><pages>1-7</pages><co_aut>et al.</co_aut></literature><literature><id>5117</id><title>The syndrome of deafness-dystonia: clinical and genetic heterogeneity</title><author>Kojovic M,</author><journal>Mov Disord</journal><year>2013</year><book /><volume>28</volume><number>6</number><pages>795-803</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>